These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 14993255)

  • 1. MHC class II expression restricted to CD8alpha+ and CD11b+ dendritic cells is sufficient for control of Leishmania major.
    Lemos MP; Esquivel F; Scott P; Laufer TM
    J Exp Med; 2004 Mar; 199(5):725-30. PubMed ID: 14993255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8alpha+ and CD11b+ dendritic cell-restricted MHC class II controls Th1 CD4+ T cell immunity.
    Lemos MP; Fan L; Lo D; Laufer TM
    J Immunol; 2003 Nov; 171(10):5077-84. PubMed ID: 14607905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Batf3-dependent CD103+ dendritic cells are major producers of IL-12 that drive local Th1 immunity against Leishmania major infection in mice.
    Martínez-López M; Iborra S; Conde-Garrosa R; Sancho D
    Eur J Immunol; 2015 Jan; 45(1):119-29. PubMed ID: 25312824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT1 expression in dendritic cells, but not T cells, is required for immunity to Leishmania major.
    Johnson LM; Scott P
    J Immunol; 2007 Jun; 178(11):7259-66. PubMed ID: 17513775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node resident rather than skin-derived dendritic cells initiate specific T cell responses after Leishmania major infection.
    Iezzi G; Fröhlich A; Ernst B; Ampenberger F; Saeland S; Glaichenhaus N; Kopf M
    J Immunol; 2006 Jul; 177(2):1250-6. PubMed ID: 16818784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-presenting dendritic cells are required for control of Leishmania major infection.
    Ashok D; Schuster S; Ronet C; Rosa M; Mack V; Lavanchy C; Marraco SF; Fasel N; Murphy KM; Tacchini-Cottier F; Acha-Orbea H
    Eur J Immunol; 2014 May; 44(5):1422-32. PubMed ID: 24643576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity.
    Matos I; Mizenina O; Lubkin A; Steinman RM; Idoyaga J
    PLoS One; 2013; 8(6):e67453. PubMed ID: 23840706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling MHC II immunopeptidome of blood-stage malaria reveals that cDC1 control the functionality of parasite-specific CD4 T cells.
    Draheim M; Wlodarczyk MF; Crozat K; Saliou JM; Alayi TD; Tomavo S; Hassan A; Salvioni A; Demarta-Gatsi C; Sidney J; Sette A; Dalod M; Berry A; Silvie O; Blanchard N
    EMBO Mol Med; 2017 Nov; 9(11):1605-1621. PubMed ID: 28935714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania major infection in major histocompatibility complex class II-deficient mice: CD8+ T cells do not mediate a protective immune response.
    Erb K; Blank C; Ritter U; Bluethmann H; Moll H
    Immunobiology; 1996 Jul; 195(2):243-60. PubMed ID: 8877400
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Letendre C; Auger JP; Lemire P; Galbas T; Gottschalk M; Thibodeau J; Segura M
    Front Immunol; 2018; 9():1199. PubMed ID: 29899744
    [No Abstract]   [Full Text] [Related]  

  • 11. Reciprocal changes in CD11c
    Yadav PK; Chandrakar P; Sharma P; Vishwakarma P; Parmar N; Srivastava M; Kar S
    Vaccine; 2020 Jan; 38(2):355-365. PubMed ID: 31648908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hierarchy of susceptibility of dendritic cell subsets to infection by Leishmania major: inverse relationship to interleukin-12 production.
    Henri S; Curtis J; Hochrein H; Vremec D; Shortman K; Handman E
    Infect Immun; 2002 Jul; 70(7):3874-80. PubMed ID: 12065531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity.
    Woelbing F; Kostka SL; Moelle K; Belkaid Y; Sunderkoetter C; Verbeek S; Waisman A; Nigg AP; Knop J; Udey MC; von Stebut E
    J Exp Med; 2006 Jan; 203(1):177-88. PubMed ID: 16418399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions.
    Abou Fakher FH; Rachinel N; Klimczak M; Louis J; Doyen N
    J Immunol; 2009 Feb; 182(3):1386-96. PubMed ID: 19155485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory Dendritic Cells, Regulated by IL-4 Receptor Alpha Signaling, Control Replication, and Dissemination of
    Hurdayal R; Nieuwenhuizen NE; Khutlang R; Brombacher F
    Front Cell Infect Microbiol; 2019; 9():479. PubMed ID: 32039054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell differentiation state and their interaction with NKT cells determine Th1/Th2 differentiation in the murine model of Leishmania major infection.
    Wiethe C; Debus A; Mohrs M; Steinkasserer A; Lutz M; Gessner A
    J Immunol; 2008 Apr; 180(7):4371-81. PubMed ID: 18354157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of CTL and nonpolarized Th cell responses by CD8alpha(+) and CD8alpha(-) dendritic cells.
    Schlecht G; Leclerc C; Dadaglio G
    J Immunol; 2001 Oct; 167(8):4215-21. PubMed ID: 11591742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo.
    Ho NI; Camps MGM; de Haas EFE; Ossendorp F
    Eur J Immunol; 2018 Jul; 48(7):1164-1173. PubMed ID: 29676785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.
    Bertholet S; Debrabant A; Afrin F; Caler E; Mendez S; Tabbara KS; Belkaid Y; Sacks DL
    Infect Immun; 2005 Oct; 73(10):6620-8. PubMed ID: 16177338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parasite Manipulation of the Invariant Chain and the Peptide Editor H2-DM Affects Major Histocompatibility Complex Class II Antigen Presentation during Toxoplasma gondii Infection.
    Leroux LP; Nishi M; El-Hage S; Fox BA; Bzik DJ; Dzierszinski FS
    Infect Immun; 2015 Oct; 83(10):3865-80. PubMed ID: 26195549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.